01 4ENTASIS THERAP
01 19309245
02 19623014
03 19968593
04 110376499
01 1Y
02 3Blank
01 2Y
02 2Blank
01 22033-04-02
02 22035-11-17
Patent Expiration Date : 2035-11-17
DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US Patent Number : 10376499
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 216974
Patent Use Code : U-2840
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-11-17
Patent Expiration Date : 2035-11-17
DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US Patent Number : 9968593
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 216974
Patent Use Code : U-2840
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-11-17
Patent Expiration Date : 2033-04-02
DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US Patent Number : 9623014
Drug Substance Claim :
Drug Product Claim :
Application Number : 216974
Patent Use Code : U-2840
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-04-02
Patent Expiration Date : 2033-04-02
DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US Patent Number : 9309245
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 216974
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-04-02
LOOKING FOR A SUPPLIER?
